Go to deals
Healthcare

Open Orphan has successfully raised capital in an oversubscribed fundraise

Open Orphan Plc has completed an equity placing to raise US$15.5 million to maximize available COVID-19 opportunities and testing.

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses: hVIVO and Venn Life Sciences, and has offices in London, Dublin, Paris and the Netherlands. The company is led by a management team with deep industry and financial experience.

Oaklins Cavendish’s sister firm finnCap, based in the UK, advised Open Orphan Plc on its oversubscribed equity fundraising of US$15.5 million.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Rotem Shani has completed an IPO
Real Estate

Rotem Shani has completed an IPO

Rotem Shani Ltd has completed an IPO to refinance and develop the company.

Learn more
Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy
Private Equity | Healthcare

Dutch Dental Group has raised new acquisition debt from ING Bank to support its growth strategy

Dutch Dental Group (DDG) has raised a new debt financing package provided by ING Bank, consisting of term loans, an acquisition facility and an RCF.

Learn more
Groupe Voie Lactée has been acquired by Initiative & Finance
Private Equity | Healthcare

Groupe Voie Lactée has been acquired by Initiative & Finance

JFC Industrie has sold Groupe Voie Lactée to Initiative & Finance.

Learn more